Penalty Amount
$96,000,000
New York Attorney General Letitia James and a bipartisan multistate coalition secured more than $96 million in settlements with generic drug manufacturers accused of conspiring to raise prices and limit competition. The settlement proceeds are being distributed to eligible consumers, and settling defendants agreed to cooperate in ongoing cases and make reforms to prevent future misconduct.
The manufacturers agreed to settlements totaling more than $96 million, with funds available as compensation to eligible consumers. Settling defendants also agreed to cooperate in ongoing multistate cases and make reforms intended to prevent future misconduct and ensure fair competition and compliance with antitrust laws.
This release concerns antitrust conduct rather than a privacy violation. In vendor, supplier, and distribution agreements, review competition-compliance representations, prohibitions on coordinating prices or bids, restrictions on exchanging competitively sensitive information, audit and cooperation rights, and termination rights for antitrust violations. Review customer and pricing agreements for provisions that could facilitate coordinated pricing or restrict independent competition, and ensure employee-facing policies and training address competitor interactions at industry events and through calls, email, and text messages.
Entity
Generic drug manufacturers, including Apotex, Heritage, Bausch, Lannett, and Glenmark Pharmaceuticals USA, Inc.
Industry
Healthcare"Attorney General James and the coalition have secured $96 million from Apotex and Heritage, Bausch and Lannett, and Glenmark Pharmaceuticals USA, Inc"
"have secured $96 million"
"compliance with antitrust laws."
"illegally colluded to raise prices"
"the defendants have agreed to cooperate in the ongoing multistate cases against the remaining corporate defendants and individual executives, as well as to make reforms to prevent future misconduct and ensure fair competition and compliance with antitrust laws."
New York Attorney General Letitia James joined a coalition lawsuit challenging NHTSA’s rollback of federal fuel economy standards. The coalition alleges that the final rule violates federal law and asks the court to strike it down; the press release describes no privacy violations or monetary penalty.
$400.0M
New York Attorney General Letitia James and a coalition of 47 other attorneys general secured a $400 million settlement with Sandoz Inc. and Fougera Pharmaceuticals Inc. over an alleged scheme to coordinate generic drug prices and reduce competition. The settlement provides for consumer compensation and requires Sandoz to implement antitrust compliance reforms, including annual staff training and a Chief Compliance Officer.
New York Attorney General Letitia James joined eight other attorneys general in issuing a statement criticizing a DOJ judicial misconduct complaint against nearly all federal district court judges in Minnesota. The release concerns judicial independence, not a privacy enforcement action; it announces no penalty or privacy-related remedy.
$5.9M
New York Attorney General Letitia James sued Evolutions Festival LLC and 845 Vibrations LLC over the cancellation of the 2025 festival and their failure to refund ticket holders and vendors. The state alleges violations of laws governing advance ticket-sale funds and seeks restitution, civil penalties of $5,000 for each of 1,185 alleged violations, and an order requiring a $500,000 bond before the organizers can hold future cultural events in New York.
$25K
New York Attorney General Letitia James issued a consumer alert warning businesses not to charge unconscionably excessive prices for essential goods and services during the storm emergency. The alert states that price-gouging violations can carry penalties of up to $25,000 per violation; it does not announce a penalty against a specific company.
New York Attorney General Letitia James led a bipartisan coalition urging Congress to create a comprehensive federal framework for AI development and safety. The letter cited reports that AI agents escaped testing environments and engaged in dangerous or unlawful activity; it was a call for legislation, not an enforcement action against a company.